Arash Velayati

1.3k total citations
39 papers, 971 citations indexed

About

Arash Velayati is a scholar working on Physiology, Oncology and Cell Biology. According to data from OpenAlex, Arash Velayati has authored 39 papers receiving a total of 971 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 8 papers in Oncology and 8 papers in Cell Biology. Recurrent topics in Arash Velayati's work include Lysosomal Storage Disorders Research (14 papers), Cellular transport and secretion (8 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). Arash Velayati is often cited by papers focused on Lysosomal Storage Disorders Research (14 papers), Cellular transport and secretion (8 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). Arash Velayati collaborates with scholars based in United States, Iran and Australia. Arash Velayati's co-authors include Ellen Sidransky, Ehud Goldin, Thai Leong Yap, Jennifer C. Lee, Wendy Westbroek, Wai Haung Yu, Nima Moaven, Rafael J. Tamargo, James M. Gruschus and Barbara Stubblefield and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Arash Velayati

37 papers receiving 954 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arash Velayati United States 15 612 414 391 182 178 39 971
Wei‐Lien Chuang United States 18 797 1.3× 371 0.9× 120 0.3× 472 2.6× 240 1.3× 28 1.1k
Laura Gort Spain 24 758 1.2× 282 0.7× 77 0.2× 629 3.5× 275 1.5× 67 1.3k
Agnieszka Ługowska Poland 20 714 1.2× 211 0.5× 47 0.1× 428 2.4× 166 0.9× 70 1.1k
Leanne K. Hein Australia 17 522 0.9× 193 0.5× 51 0.1× 232 1.3× 129 0.7× 34 734
I Maire France 17 785 1.3× 188 0.5× 54 0.1× 341 1.9× 228 1.3× 85 1.2k
Helena Poupětová Czechia 17 932 1.5× 272 0.7× 36 0.1× 302 1.7× 196 1.1× 40 1.1k
Tina Rozaklis Australia 17 659 1.1× 253 0.6× 24 0.1× 236 1.3× 145 0.8× 24 835
Brady Ro United States 19 1.1k 1.9× 350 0.8× 78 0.2× 594 3.3× 326 1.8× 44 1.6k
Barbara Czartoryska Poland 21 980 1.6× 299 0.7× 37 0.1× 292 1.6× 257 1.4× 67 1.2k
Jakub Sikora Czechia 20 487 0.8× 186 0.4× 28 0.1× 507 2.8× 137 0.8× 48 1.1k

Countries citing papers authored by Arash Velayati

Since Specialization
Citations

This map shows the geographic impact of Arash Velayati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arash Velayati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arash Velayati more than expected).

Fields of papers citing papers by Arash Velayati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arash Velayati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arash Velayati. The network helps show where Arash Velayati may publish in the future.

Co-authorship network of co-authors of Arash Velayati

This figure shows the co-authorship network connecting the top 25 collaborators of Arash Velayati. A scholar is included among the top collaborators of Arash Velayati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arash Velayati. Arash Velayati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Velayati, Arash, et al.. (2023). Clinical outcomes of patients who underwent total neoadjuvant therapy (TNT) for locally advanced rectal cancer (LARC): A single center experience.. Journal of Clinical Oncology. 41(16_suppl). e15630–e15630. 1 indexed citations
3.
Velayati, Arash, et al.. (2021). Thoracic Osteomyelitis and Eustachian Valve Endocarditis: A Case Report and Literature Review. Cureus. 13(3). e13810–e13810. 2 indexed citations
4.
Adkison, Jarrod B., et al.. (2021). Can Discord Domain-Containing Receptor 2 Mutation Act as a Disease Modifier for PRKAR1A Associated Melanotic Schwannoma?. Case Reports in Oncology. 14(2). 826–831. 1 indexed citations
5.
Velayati, Arash, et al.. (2021). Understanding the Differences in COVID-19 Case Fatality Rates Observed Across Alabama Counties. Journal of Public Health Management and Practice. 27(3). 305–309. 2 indexed citations
6.
Georgiopoulou, Vasiliki V., Arash Velayati, Song Li, et al.. (2018). Comorbidities, Sociodemographic Factors, and Hospitalizations in Outpatients With Heart Failure and Preserved Ejection Fraction. The American Journal of Cardiology. 121(10). 1207–1213. 14 indexed citations
7.
Schloss, Michael, et al.. (2018). Postprostatectomy radiation therapy for biochemically recurrent prostate cancer. 1 indexed citations
8.
Velayati, Arash, et al.. (2016). Promising new therapies for the treatment of hypercholesterolemia. Expert Opinion on Biological Therapy. 16(5). 609–618. 8 indexed citations
9.
Siebert, Marina, Wendy Westbroek, Yu‐Chi Chen, et al.. (2014). Identification of miRNAs that modulate glucocerebrosidase activity in Gaucher disease cells. RNA Biology. 11(10). 1291–1300. 35 indexed citations
10.
Velayati, Arash, et al.. (2013). New development of cardiac tamponade on underlying effusive–constrictive pericarditis: an uncommon initial presentation of scleroderma. BMJ Case Reports. 2013. bcr2013010254–bcr2013010254. 11 indexed citations
11.
Tamargo, Rafael J., Arash Velayati, Ehud Goldin, & Ellen Sidransky. (2012). The role of saposin C in Gaucher disease. Molecular Genetics and Metabolism. 106(3). 257–263. 101 indexed citations
12.
Yap, Thai Leong, Arash Velayati, Ellen Sidransky, & Jennifer C. Lee. (2012). Membrane-bound α-synuclein interacts with glucocerebrosidase and inhibits enzyme activity. Molecular Genetics and Metabolism. 108(1). 56–64. 88 indexed citations
13.
Yap, Thai Leong, James M. Gruschus, Arash Velayati, et al.. (2011). α-Synuclein Interacts with Glucocerebrosidase Providing a Molecular Link between Parkinson and Gaucher Diseases. Journal of Biological Chemistry. 286(32). 28080–28088. 137 indexed citations
14.
Velayati, Arash, Nidhi Gupta, Jae Hyuk Choi, et al.. (2011). A mutation in SCARB2 is a modifier in gaucher disease. Human Mutation. 32(11). 1232–1238. 68 indexed citations
15.
Choi, Jae Hyuk, Barbara Stubblefield, Mark Cookson, et al.. (2011). Aggregation of α-synuclein in brain samples from subjects with glucocerebrosidase mutations. Molecular Genetics and Metabolism. 104(1-2). 185–188. 61 indexed citations
16.
Raeisossadati, Reza, Moein Farshchian, Azita Ganji, et al.. (2011). Quantitative analysis of TEM-8 and CEA tumor markers indicating free tumor cells in the peripheral blood of colorectal cancer patients. International Journal of Colorectal Disease. 26(10). 1265–1270. 23 indexed citations
17.
Velayati, Arash, Wai Haung Yu, & Ellen Sidransky. (2010). The Role of Glucocerebrosidase Mutations in Parkinson Disease and Lewy Body Disorders. Current Neurology and Neuroscience Reports. 10(3). 190–198. 104 indexed citations
18.
Miri‐Moghaddam, Ebrahim, Arash Velayati, Majid Naderi, Nahid Tayebi, & Ellen Sidransky. (2010). Coinheritance of Gaucher disease and α-thalassemia resulting in confusion between two inherited hematologic diseases. Blood Cells Molecules and Diseases. 46(1). 88–91. 2 indexed citations
19.
Azarpazhooh, Mahmoud Reza, Naghmeh Mokhber, Elias Orouji, et al.. (2010). Microembolic Signals in Patients with Systemic Lupus Erythematosus. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 37(3). 371–375. 5 indexed citations
20.
Velayati, Arash, et al.. (2007). SHORT REPORT: RAPID DNA EXTRACTION PROTOCOL FROM STOOL, SUITABLE FOR MOLECULAR GENETIC DIAGNOSIS OF COLON CANCER. 11(3). 203–208. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wei‐Lien Chuang Breakdown of academic impact, for papers by Laura Gort Breakdown of academic impact, for papers by Agnieszka Ługowska Breakdown of academic impact, for papers by Leanne K. Hein Breakdown of academic impact, for papers by I Maire Breakdown of academic impact, for papers by Helena Poupětová Breakdown of academic impact, for papers by Tina Rozaklis Breakdown of academic impact, for papers by Brady Ro Breakdown of academic impact, for papers by Barbara Czartoryska Breakdown of academic impact, for papers by Jakub Sikora
Rankless by CCL
2026